According to previously published results, this mutation accounts for 31% of the BRCA1 and BRCA2 mutations identified in Greek familial breast/ovarian cancer patients (Ladopoulou et al, 2002; Konstantopoulou et al, 2008). This evidence concerns the gene BRCA1 and ovarian cancer.